Analysis of the Cellular Mechanism Underlying Inhibition of EAE After Treatment with Anti-NKG2A F(ab')2
Overview
Affiliations
Autoimmune encephalomyelitis may be ameliorated experimentally by enhancing NK cell-mediated elimination of activated autoreactive T cells through a mutation that interrupts the interaction between Qa-1(b) and CD94/NKG2A. Here we evaluate the ability of an anti-NKG2A F(ab')(2) Ab to enhance elimination of autoreactive T cells and reduce experimental autoimmune encephalomyelitis (EAE). Anti-NKG2A F(ab')(2) treatment diminishes progression of both myelin oligodendrocyte glycoprotein (MOG)-induced EAE in intact C57BL/6 mice and after adoptive transfer of disease-causing T cells. Analyses of the underlying mechanism revealed that administration of anti-NKG2A F(ab')(2) Ab reduces CD4(+) T recall responses to MOG and skews the proportion of IL-17- and IFNgamma-producing CD4(+) T cells toward the protective IL-4- and IL-10-secreting CD4(+) T cell subpopulations. CD94/NKG2A-dependent inhibition of inflammatory damage to spinal cord is associated with decreased infiltration of T cells and reduced microglia activation in the central nervous system. Because anti-NKG2A F(ab')(2) treatment had no detectable effect on the numbers or activity of T and B lymphocytes and NK cells in peripheral lymphoid tissues, this anti-NKG2A-based approach may represent a safe and effective therapy for this CNS disorder.
Ngiow S, Manne S, Huang Y, Azar T, Chen Z, Mathew D Cell. 2024; 187(16):4336-4354.e19.
PMID: 39121847 PMC: 11337978. DOI: 10.1016/j.cell.2024.07.018.
Weber S, Menees K, Park J, Agin-Liebes J, Lin C, Alcalay R NPJ Parkinsons Dis. 2024; 10(1):36.
PMID: 38360903 PMC: 10869354. DOI: 10.1038/s41531-024-00652-y.
Implications of NKG2A in immunity and immune-mediated diseases.
Wang X, Xiong H, Ning Z Front Immunol. 2022; 13:960852.
PMID: 36032104 PMC: 9399941. DOI: 10.3389/fimmu.2022.960852.
Interaction Between Innate Lymphoid Cells and the Nervous System.
Zhang Y, Grazda R, Yang Q Adv Exp Med Biol. 2022; 1365:135-148.
PMID: 35567745 DOI: 10.1007/978-981-16-8387-9_9.
NK Cells in Autoimmune Diseases: Protective or Pathogenic?.
Liu M, Liang S, Zhang C Front Immunol. 2021; 12:624687.
PMID: 33777006 PMC: 7994264. DOI: 10.3389/fimmu.2021.624687.